| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/24/2008 | WO2008089164A1 Compositions and methods inducing fibrosis |
| 07/24/2008 | WO2008089070A2 Combination therapy for the treatment of cancer |
| 07/24/2008 | WO2008088875A2 Method of treating hepatitis c virus |
| 07/24/2008 | WO2008088849A2 Inflammation treatment, detection and monitoring via trem-1 |
| 07/24/2008 | WO2008088822A1 Inhibiting staphylococcus epidermidis infections |
| 07/24/2008 | WO2008088810A2 Formulations for cosmetic and wound care treatments with photosensitizers as fluorescent markers |
| 07/24/2008 | WO2008088548A2 Disintegrin variants and pharmaceutical uses thereof |
| 07/24/2008 | WO2008088524A2 Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor |
| 07/24/2008 | WO2008088422A2 Toxin peptide therapeutic agents |
| 07/24/2008 | WO2008088331A1 Methods for increasing levels of human fetal hemoglobin |
| 07/24/2008 | WO2008087803A1 Liposome preparation for iontophoresis having antioxidant component encapsulated therein |
| 07/24/2008 | WO2008087419A2 Animal model for adhd |
| 07/24/2008 | WO2008087216A1 Use of platelet glycopeptide iiia epitopes in the treatment of immune thrombocytopenic purpura |
| 07/24/2008 | WO2008087189A2 Peptides for use in the treatment of obesity |
| 07/24/2008 | WO2008087188A2 Peptides for use in the treatment of obesity |
| 07/24/2008 | WO2008087187A1 Peptides for use in the treatment of obesity |
| 07/24/2008 | WO2008087186A2 Peptides for use in the treatment of obesity |
| 07/24/2008 | WO2008087025A2 Specific therapy and medicament using integrin ligands for treating cancer |
| 07/24/2008 | WO2008086858A1 Production and use of non-native variants of domain 2 of human placental bikunin designed by directed molecular evolution |
| 07/24/2008 | WO2008086813A2 Peptides derived from proteins of the insulin super-family |
| 07/24/2008 | WO2008086716A1 Layered double hydroxide complex inserted by dipeptiven and the preparation method thereof |
| 07/24/2008 | WO2008086612A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/24/2008 | WO2008086610A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/24/2008 | WO2008086573A1 Use of galanin in a method of treating neurodegenerative diseases or conditions |
| 07/24/2008 | WO2008070552A3 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 07/24/2008 | WO2008070141A3 Compositions for delivery of therapeutic agents |
| 07/24/2008 | WO2008066845A3 Treatment of metabolic syndrome with norfluoxetine |
| 07/24/2008 | WO2008064465B1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan |
| 07/24/2008 | WO2008053250A3 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser |
| 07/24/2008 | WO2008048691A3 Use of leptin for treating post-lipectomy ectopic fat deposition and other post-lipectomy associated disorders |
| 07/24/2008 | WO2008048607A3 Collagen peptides as immune modulators |
| 07/24/2008 | WO2008045238A3 Stabilized therapeutic small helical antiviral peptides |
| 07/24/2008 | WO2008042260A3 Methods of treating hyperandrogenism and conditions associated therewith by administering a fatty acid ester of an estrogen or an estrogen derivative |
| 07/24/2008 | WO2008020741A3 Method for extracting phospholipase a2 from agkistrodon blomhoffii venom |
| 07/24/2008 | WO2008009635A3 Factor viia analogues with increased activity for treating thrombocytopenia |
| 07/24/2008 | WO2008005527A8 Glucagon-like peptides and uses thereof |
| 07/24/2008 | WO2007132445A3 Use of non-catalytic form of heparanase and peptides thereof for reversing the anti-coagulant effects of heparinoids |
| 07/24/2008 | WO2007118051A3 Lipid therapy |
| 07/24/2008 | WO2007117536A3 Calcium phosphate complex in acid containing chewing gum |
| 07/24/2008 | WO2007092447A3 Methods and compositions related to targeting tumors and wounds |
| 07/24/2008 | WO2007053533A8 Sodium chloride solution for drug reconstitution or dilution |
| 07/24/2008 | WO2005103063A3 Apparatus and method for mixed-bed lectin chromatography |
| 07/24/2008 | WO2005076979A3 Diagnosis and therapeutics for cancer |
| 07/24/2008 | WO2004071573A3 Hypoxia induced mitogenic factor |
| 07/24/2008 | WO2004067717A3 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera |
| 07/24/2008 | US20080178310 Transgenic fish comprising myostatin insertional disruption for use in production of progeny with increased muscle mass and reduced cholesterol concentrations |
| 07/24/2008 | US20080178308 Immunoglobulin specific to prostate tumor associated protein (24P4C12) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/24/2008 | US20080177248 Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders |
| 07/24/2008 | US20080177042 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080177041 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 07/24/2008 | US20080177037 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080177036 Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity |
| 07/24/2008 | US20080177035 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides |
| 07/24/2008 | US20080177033 Self-Assembly of Peptide-Amphiphile Nanofibers under Physiological Conditions |
| 07/24/2008 | US20080177029 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |
| 07/24/2008 | US20080176961 Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain |
| 07/24/2008 | US20080176953 Administration of a neuroprotectant( brimonidine, clonidine and para-aminoclonidine) for the treatment of ocular neovascularization (CNV) and macular degeneration; Vision defects; photodynamic therapy; mixture of neuroprotective factor and neovascularization inhibitor |
| 07/24/2008 | US20080176944 Elongase Genes and Uses Thereof |
| 07/24/2008 | US20080176901 Compounds and compositions as channel activating protease inhibitors |
| 07/24/2008 | US20080176814 nonpeptidic inhibitors of cathepsin G; genetic diseases, degenerative diseases, DNA damages, neoplasia and/or skin diseases; DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing |
| 07/24/2008 | US20080176807 Facially amphiphilic polymers and oligomers and uses thereof |
| 07/24/2008 | US20080176806 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 07/24/2008 | US20080176805 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/24/2008 | US20080176804 Methods for Affecting Body Composition |
| 07/24/2008 | US20080176803 or Nicastrin complex with the novel protein Sambiasin; drugs screening, drug targets, diagnosis or prognosis of Alzheimer's disease; neurodegenerative diseases and developmental disorders caused by defects in the Notch pathway; fusion protein |
| 07/24/2008 | US20080176802 Methods of Use for Conjugated Exendin Peptides |
| 07/24/2008 | US20080176801 Axmi-004, a delta-endotoxin gene and methods for its use |
| 07/24/2008 | US20080176800 Methods for the delivery of bioactive substances with biodegradable polyphosphates |
| 07/24/2008 | US20080176799 a mixture of transforming growth factor and sugar selected from maltose, sucrose, glucose or mannose, used as wound healing and antiscarring agents |
| 07/24/2008 | US20080176798 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 07/24/2008 | US20080176797 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/24/2008 | US20080176796 screening for selective antagonists or agonists of tumor necrosis factor receptors, used as antiinflammatory or antiischemic agents; treatment of cardiovascular and kidney diseases |
| 07/24/2008 | US20080176795 administering human H3 relaxin, carriers, diluents and/or excipients; anxiolytic agents; hormones |
| 07/24/2008 | US20080176794 Long lasting fusion peptide inhibitors of viral infection |
| 07/24/2008 | US20080176793 Upregulating activity or expression of bdnf to mitigate cognitive impairment in asymptomatic huntington's subjects |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080176791 a mixture of antihemophilic factor, bulking agent selected from mannitol, glycine and alanine, stabilizer agents selected from sucrose, trehalose, raffinose and arginine, calcium chloride, sodium chloride and buffers, having storage stability |
| 07/24/2008 | US20080176790 mutants of fibroblast growth factors containing N-linked or O-linked glycosylation sites ;drug-polymer conjugates, used for treating fibroblast growth factor deficiency in patients |
| 07/24/2008 | US20080176789 comprising subjecting the materials to sequential chromatography on an anion-exchange matrix and a hydrophobic interaction matrix such as material is phenyl sepharose, to produce blood-coagulation factor XIII polypeptides precipitates, used for preventing bleeding and treating blood disorders |
| 07/24/2008 | US20080176788 Apo-2 ligand |
| 07/24/2008 | US20080176787 Parathyroid hormone analogues and methods of use |
| 07/24/2008 | US20080176786 Transgenically produced antithrombin III |
| 07/24/2008 | US20080176785 Controlled release compositions |
| 07/24/2008 | US20080176323 Expression vector comprising nucleotide sequences coding cytokine polypeptide for use in treatment and prevention of lung, viral, cell proliferative and inflammatory diseases |
| 07/24/2008 | US20080176312 Using immunoaffinity chromatography to isolate blood coagulation factor; treatment of myeloproliferative and thrombotic disorders |
| 07/24/2008 | US20080176285 N-acetyl glucosamine phosphotransferase for use in treatment and prevention of lysosomal storage diseases |
| 07/24/2008 | US20080176281 Transgenic cell for use as bioreactor in expression of polypeptide for treating arthritis |
| 07/24/2008 | US20080176279 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 07/24/2008 | US20080176268 MN Gene and Protein |
| 07/24/2008 | US20080176243 Designing vector system comprising regulatory sequences which utilize human chorionic gonadotropin and/or nuclear factor kappaB as modulators of genic expression |
| 07/24/2008 | US20080176234 Using oxytocin receptor as screening tool to identify modulator for treatment and prevention of lung and colon cancers |
| 07/24/2008 | US20080176231 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 07/24/2008 | US20080176223 Expression vector comprising polymerase regulatory sequences for use as tool in identifying modulators of eukaryotic transcription |
| 07/24/2008 | US20080175925 Comprising an antiviral agent (chlorhexidine), an antioxidant agent (reduced glutathione), and an analgesic agent (lidocaine); oral application to mouth tissue; cold sores |
| 07/24/2008 | US20080175921 Once daily, low viscosity; very fine needle injectable suspension; pharmacokinetic performance |
| 07/24/2008 | US20080175916 Advancing distal portion of catheter to existing blood vessel and releasing medicant |
| 07/24/2008 | US20080175911 Compositions and methods for soft tissue repair |
| 07/24/2008 | US20080175907 Oral insulin therapies and protocol |
| 07/24/2008 | US20080175896 high affinity to a fibroblast growth factor-inducible 14 (Fn14) cell surface receptor; induce cell death; drug target at diseased cell of cancer, atherosclerosis, stroke, lupus, nephritis, multiple sclerosis, rheumatoid arthritis, degenerative or inflammation; reduce side effect |
| 07/24/2008 | US20080175895 System, devices, and methods for iontophoretic delivery of compositions including antioxidants encapsulated in liposomes |